NCT02837783View on ClinicalTrials.gov

A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

PHASE4TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 21, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Irritable Bowel Syndrome Characterized by Constipation
Interventions
DRUG

Linaclotide

Oral, once daily

DRUG

Placebo

Oral, one daily

Trial Locations (1)

Unknown

Peter Whorwell, Wythenshawe

Sponsors
All Listed Sponsors
collaborator

Manchester University NHS Foundation Trust

OTHER_GOV

lead

Ironwood Pharmaceuticals, Inc.

INDUSTRY

NCT02837783 - A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C) | Biotech Hunter | Biotech Hunter